Selexys Pharmaceuticals, Inc.
5Patents
5Active
5Granted
45Portfolio score
Filing activity: Nov 30, 2007 → Feb 1, 2013 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8377440B2 | Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases | Chemistry; Metallurgy | 6 | Active |
| US7833530B2 | Methods of inhibiting the PSGL-1-mediated adhesion and chemokine-mediated migration with PSGL-1-specific antibodies | Physics | 5 | Active |
| US8945565B2 | Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies | Chemistry; Metallurgy | 2 | Active |
| US9068001B2 | Anti-P-selectin antibodies | Chemistry; Metallurgy | 2 | Active |
| US9556266B2 | Methods of treating sickle cell disease with anti-P-selectin antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.